Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Furoate in Perennial Allergic Rhinitis
NCT00103454Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Primary completion
- May 2005
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of fluticasone in perennial allergic rhinitis (PAR), sponsored by GSK. Started Jan 2005; status: completed.
02
Drugs
fluticasone
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00103454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103454.